International Clinical Trial: A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (CTIS2024-520154-38-00) titled 'A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia' on Feb. 14.

Study Type: Interventional clinical trial of medicinal product

Study Design: Controlled: no Randomised: no Open: no Single blind: no Double blind: no Parallel group: no Cross over: no Other: no If controlled, specify comparator, Other Medicinial Product: no Placebo: no Number of treatment arms in the trial:

Primary Sponsor: Janssen Cilag International

Condition: Acute Myeloid Luekemia MedDRA version: 21.0Level: LLTClassification code: 10000886Term: Acute myeloid leuke...